Lisa Murphy leads strategic client engagements focused on legislative and regulatory changes to the healthcare system.

She supports pharmaceutical manufacturers in preparing for, interpreting, and responding to policy changes resulting from the Affordable Care Act, including the implementation of health insurance exchanges, essential health benefits requirements, and Medicaid expansions. Lisa’s other areas of expertise include the Medicare prescription drug benefit and state policies on prescription drug access.

Prior to joining Avalere, Lisa worked with the Department of Health and Human Services and the Centers for Medicare & Medicaid Services as a consultant with Booz Allen Hamilton and served as a Jacob K. Javits Policy Fellow in the Office of U.S. Sen. Jean Carnahan.

Lisa has a MPP from the Terry Sanford Institute of Public Policy at Duke University, and graduated Phi Beta Kappa with a BA in political science from the University of Richmond.

Authored Content


Increasingly, states are taking steps to control prescription drug spending and prices.

The number of drugs health plans are required to cover in the individual and small group markets will vary dramatically by state in 2014.